Uswm Ct, Llc

This study tests a new treatment called ADP-A2M4 for people with advanced synovial sarcoma or myxoid liposarcoma that has spread or cannot be removed by surgery. The treatment uses a patient's own immune cells that are genetically modified to recognize and attack cancer cells car…

This study tests a special type of immune cell (engineered T-cells) designed to recognize and attack cancer cells in people with advanced solid tumors. About 103 participants with specific genetic markers (HLA-A2) and tumor proteins (NY-ESO-1) will receive these cells alone or wi…

This early-phase study tests a personalized cell therapy (ADP-A2M4CD8) for people with advanced cancers like lung, ovarian, or melanoma that have a specific marker called MAGE-A4. The treatment uses the patient's own immune cells, modified to better attack the cancer, and is give…

This study tests a treatment called Lete-Cel for people with advanced synovial sarcoma or myxoid/round cell liposarcoma that has not responded to prior therapy. The treatment uses specially engineered immune cells to target and attack the cancer. The goal is to see if it can shri…